These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22298786)

  • 1. Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.
    Lorente E; García R; Mir C; Barriga A; Lemonnier FA; Ramos M; López D
    J Biol Chem; 2012 Mar; 287(13):9990-10000. PubMed ID: 22298786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological remarks about TAP deficiency.
    Zimmer J; Sleiman M; Hentges F; Gadola SD
    J Biol Chem; 2012 Aug; 287(32):27047; author reply 27048. PubMed ID: 22865894
    [No Abstract]   [Full Text] [Related]  

  • 3. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
    Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
    J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.
    Lorente E; Infantes S; Barnea E; Beer I; García R; Lasala F; Jiménez M; Vilches C; Lemonnier FA; Admon A; López D
    J Virol; 2012 Jan; 86(1):527-41. PubMed ID: 22031944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.
    Lee SP; Thomas WA; Blake NW; Rickinson AB
    Eur J Immunol; 1996 Aug; 26(8):1875-83. PubMed ID: 8765034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
    Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
    Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.
    Lorente E; García R; López D
    J Biol Chem; 2011 Nov; 286(44):38054-38059. PubMed ID: 21914809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
    Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
    J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination and the TAP-independent antigen processing pathways.
    López D; Lorente E; Barriga A; Johnstone C; Mir C
    Expert Rev Vaccines; 2013 Sep; 12(9):1077-83. PubMed ID: 24053400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.
    Lorente E; Infantes S; Barnea E; Beer I; Barriga A; García-Medel N; Lasala F; Jiménez M; Admon A; López D
    PLoS One; 2013; 8(3):e59118. PubMed ID: 23555621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing.
    Snyder HL; Bacík I; Bennink JR; Kearns G; Behrens TW; Bächi T; Orlowski M; Yewdell JW
    J Exp Med; 1997 Oct; 186(7):1087-98. PubMed ID: 9314557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.
    Terajima M; Orphin L; Leporati AM; Pazoles P; Cruz J; Rothman AL; Ennis FA
    Hum Immunol; 2008 Dec; 69(12):815-25. PubMed ID: 18955096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
    Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
    J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.
    López D; García-Calvo M; Smith GL; Del Val M
    J Immunol; 2010 May; 184(9):5193-9. PubMed ID: 20348426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules.
    Magnacca A; Persiconi I; Nurzia E; Caristi S; Meloni F; Barnaba V; Paladini F; Raimondo D; Fiorillo MT; Sorrentino R
    J Biol Chem; 2012 Aug; 287(36):30358-67. PubMed ID: 22807446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.